Skip Navigation LinksHome > May 1, 2014 - Volume 66 - Issue 1 > Dual Therapy With Lamivudine + Protease Inhibitor During Pre...
Text sizing:
A
A
A
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/01.qai.0000446535.31520.3c
Erratum

Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of Mother-to-Child Transmission of HIV-1: Erratum

Free Access

In the article by Gliga et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 63, No. 5, pp. e159-e163 entitled “Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of Mother-to-Child Transmission of HIV-1”, the author Marc A. Dommergues should appear as Marc Dommergues.

Back to Top | Article Outline

REFERENCE

Gliga S, Clavel CO, Alix AF, et al.. Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr. 2013;63:e159–e163.

© 2014 by Lippincott Williams & Wilkins

Login